Annual SGA
$93.27 M
+$10.44 M+12.60%
December 31, 2023
Summary
- As of February 28, 2025, URGN annual SGA is $93.27 million, with the most recent change of +$10.44 million (+12.60%) on December 31, 2023.
- During the last 3 years, URGN annual SGA has risen by +$3.06 million (+3.39%).
- URGN annual SGA is now at all-time high.
Performance
URGN SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$28.94 M
-$1.11 M-3.71%
September 30, 2024
Summary
- As of February 28, 2025, URGN quarterly SGA is $28.94 million, with the most recent change of -$1.11 million (-3.71%) on September 30, 2024.
- Over the past year, URGN quarterly SGA has increased by +$7.19 million (+33.03%).
- URGN quarterly SGA is now -3.71% below its all-time high of $30.06 million, reached on June 30, 2024.
Performance
URGN Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.90 B
-$115.38 M-4.14%
September 30, 2024
Summary
- As of February 28, 2025, URGN TTM SGA is -$2.90 billion, with the most recent change of -$115.38 million (-4.14%) on September 30, 2024.
- Over the past year, URGN TTM SGA has dropped by -$3.00 billion (-3314.72%).
- URGN TTM SGA is now -10573.66% below its all-time high of -$27.21 million.
Performance
URGN TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
URGN Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.6% | +33.0% | -3314.7% |
| 3 y3 years | +3.4% | +33.8% | -3390.4% |
| 5 y5 years | +135.7% | +107.1% | -4925.2% |
URGN Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +12.6% | -3.7% | +51.8% | -71.1% | at low |
| 5 y | 5-year | at high | +54.9% | -3.7% | +51.8% | -298.9% | at low |
| alltime | all time | at high | +4822.1% | -3.7% | +3207.5% | <-9999.0% | at low |
UroGen Pharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $28.94 M(-3.7%) | $110.85 M(+6.9%) |
| Jun 2024 | - | $30.06 M(+10.1%) | $103.66 M(+7.9%) |
| Mar 2024 | - | $27.30 M(+11.2%) | $96.10 M(+3.0%) |
| Dec 2023 | $93.27 M(+12.6%) | $24.55 M(+12.9%) | $93.27 M(+3.2%) |
| Sep 2023 | - | $21.75 M(-3.3%) | $90.36 M(+3.1%) |
| Jun 2023 | - | $22.49 M(-8.1%) | $87.67 M(+1.9%) |
| Mar 2023 | - | $24.47 M(+13.1%) | $86.01 M(+3.8%) |
| Dec 2022 | $82.84 M(-5.4%) | $21.63 M(+13.4%) | $82.84 M(+0.3%) |
| Sep 2022 | - | $19.07 M(-8.5%) | $82.62 M(-3.0%) |
| Jun 2022 | - | $20.83 M(-2.2%) | $85.17 M(-1.7%) |
| Mar 2022 | - | $21.30 M(-0.6%) | $86.65 M(-1.0%) |
| Dec 2021 | $87.53 M(-3.0%) | $21.42 M(-1.0%) | $87.53 M(-0.8%) |
| Sep 2021 | - | $21.62 M(-3.0%) | $88.28 M(-0.5%) |
| Jun 2021 | - | $22.30 M(+0.5%) | $88.72 M(-1.9%) |
| Mar 2021 | - | $22.19 M(+0.1%) | $90.44 M(+0.2%) |
| Dec 2020 | $90.22 M | $22.16 M(+0.4%) | $90.22 M(+2.8%) |
| Sep 2020 | - | $22.07 M(-8.1%) | $87.80 M(+10.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $24.02 M(+9.3%) | $79.71 M(+14.7%) |
| Mar 2020 | - | $21.97 M(+11.3%) | $69.47 M(+15.4%) |
| Dec 2019 | $60.20 M(+52.1%) | $19.75 M(+41.3%) | $60.20 M(+13.6%) |
| Sep 2019 | - | $13.97 M(+1.4%) | $53.01 M(+6.5%) |
| Jun 2019 | - | $13.78 M(+8.4%) | $49.78 M(+7.7%) |
| Mar 2019 | - | $12.71 M(+1.2%) | $46.21 M(+16.8%) |
| Dec 2018 | $39.57 M(+349.1%) | $12.55 M(+16.8%) | $39.57 M(+29.9%) |
| Sep 2018 | - | $10.74 M(+5.3%) | $30.46 M(+39.0%) |
| Jun 2018 | - | $10.21 M(+68.2%) | $21.91 M(+56.5%) |
| Mar 2018 | - | $6.07 M(+76.6%) | $14.01 M(+58.9%) |
| Dec 2017 | $8.81 M(+37.3%) | $3.44 M(+56.3%) | $8.81 M(+33.4%) |
| Sep 2017 | - | $2.20 M(-4.4%) | $6.60 M(-13.6%) |
| Jun 2017 | - | $2.30 M(+162.9%) | $7.64 M(+19.7%) |
| Mar 2017 | - | $875.00 K(-28.8%) | $6.38 M(+15.9%) |
| Dec 2016 | $6.42 M(+238.6%) | $1.23 M(-62.0%) | $5.51 M(+28.7%) |
| Sep 2016 | - | $3.24 M(+210.1%) | $4.28 M(+310.1%) |
| Jun 2016 | - | $1.04 M | $1.04 M |
| Dec 2015 | $1.90 M | - | - |
FAQ
- What is UroGen Pharma annual SGA?
- What is the all time high annual SGA for UroGen Pharma?
- What is UroGen Pharma annual SGA year-on-year change?
- What is UroGen Pharma quarterly SGA?
- What is the all time high quarterly SGA for UroGen Pharma?
- What is UroGen Pharma quarterly SGA year-on-year change?
- What is UroGen Pharma TTM SGA?
- What is the all time high TTM SGA for UroGen Pharma?
- What is UroGen Pharma TTM SGA year-on-year change?
What is UroGen Pharma annual SGA?
The current annual SGA of URGN is $93.27 M
What is the all time high annual SGA for UroGen Pharma?
UroGen Pharma all-time high annual SGA is $93.27 M
What is UroGen Pharma annual SGA year-on-year change?
Over the past year, URGN annual SGA has changed by +$10.44 M (+12.60%)
What is UroGen Pharma quarterly SGA?
The current quarterly SGA of URGN is $28.94 M
What is the all time high quarterly SGA for UroGen Pharma?
UroGen Pharma all-time high quarterly SGA is $30.06 M
What is UroGen Pharma quarterly SGA year-on-year change?
Over the past year, URGN quarterly SGA has changed by +$7.19 M (+33.03%)
What is UroGen Pharma TTM SGA?
The current TTM SGA of URGN is -$2.90 B
What is the all time high TTM SGA for UroGen Pharma?
UroGen Pharma all-time high TTM SGA is -$27.21 M
What is UroGen Pharma TTM SGA year-on-year change?
Over the past year, URGN TTM SGA has changed by -$3.00 B (-3314.72%)